Exploring the Relationship Between ICOPE Framework and Frailty Among Community-dwelling Elderly Individuals
1 other identifier
observational
135
1 country
1
Brief Summary
This study aims to (1) compare the assessment outcome of the ICOPE-I and ICOPE-S, and (2) investigate the correlation between both versions of the ICOPE step 1 screening tools and frailty in Taiwan.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 9, 2023
CompletedFirst Posted
Study publicly available on registry
November 18, 2023
CompletedStudy Start
First participant enrolled
December 2, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 25, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 25, 2024
CompletedAugust 12, 2024
November 1, 2023
7 months
November 9, 2023
August 8, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Intrinsic capacity
ICOPE screening tool (self-administration and interview version) would be used to evaluate the intrinsic capacity(IC), including cognitive decline, auditory and visual capabilities, mobility restrictions, nutritional status, and depressive symptoms) of the participants. Each question requires a binary response, either 'yes' or 'no'. A "total score" will be determined by summing the number of IC impairments, which have a score range of 0-6, with higher scores indicating a greater degree of impairment.
The ICOPE screening tool assessment would take about 10 minutes
Phenotype of frailty status
Frailty criteria by Dr. Fried would be used to evaluate the frail status of the participants.The Dr. Fried phenotype of frailty comprises five components, unintentional weight loss, exhaustion, weakness, slowness, and low activity. Individuals who exhibit three or more indicators are classified as frail, those with one to two indicators are categorized as pre-frail, and those with no indicators are characterized as robust.
The phenotype of frailty status assessment would take about 10 minutes
Accumulated frailty status
Edmonton frail scale(EFS) would be used to evaluate the frail status of the participants. EFS assesses a wide range of nine domains through 11 questions. These domains cover cognition, general health status, functional independence, social support, medication use, nutrition, mood, continence, and functional performance. The total score of EFS ranges from 0 to 17, where scores of 0-5 indicate not being frail, 6-7 indicate being vulnerable, 8-9 indicate mild frailty, 10-11 indicate moderate frailty and 12-17 indicate severe frailty.
The accumulated frailty status assessment would take about 10 minutes
Secondary Outcomes (1)
Cognitive status
The cognitive status assessment would take about 10 minutes
Study Arms (2)
Decline ICOPE group
The elderly individuals who have at least one impairment in ICOPE screening domains.
Non-decline ICOPE group
The elderly individuals who do not have any impairment in ICOPE screening domains.
Interventions
MoCA would be used to assess participants cognitive functioning.
The ICOPE screening tool would be used to assess participants health status, including cognitive decline, auditory and visual capabilities, mobility restrictions, nutritional status, and depressive symptoms.
The Edmonton frail scale and Frailty criteria by Dr. Fried would be used to assess participants frailty status.
Eligibility Criteria
Communities in Taipei city
You may qualify if:
- ≥ 65 years old
- Community-dwelling elderly
- Walking independently (with/without assistive devices)
You may not qualify if:
- Participants with a MoCA score \< 26
- Being unable to give informed consent (e.g., aphasia, deafness, and blindness)
- Being unable to finish all the physical and screening assessment assessments
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
School and Graduate Institute of Physical Therapy, College of Medicine, National Taiwan University
Taipei, Zhongzheng, 100, Taiwan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Li-Ying Wang, PhD
National Taiwan University
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 9, 2023
First Posted
November 18, 2023
Study Start
December 2, 2023
Primary Completion
June 25, 2024
Study Completion
June 25, 2024
Last Updated
August 12, 2024
Record last verified: 2023-11